What You Need to Know
• Increlex is a drug developed 15 years ago that can increase height for children with Laron syndrome.
• The cost of Increlex exceeds $800 per bottle, and children require at least three bottles monthly.
• Mayra Loaiza’s daughter, Camila, has not started her treatment six months after it was supposed to begin.
Increlex, a medication developed 15 years ago, offers hope for children with Laron syndrome by potentially increasing their height during growth spurts. However, accessing this drug can be challenging due to its high cost, which exceeds $800 per bottle, and the requirement of at least three bottles monthly, totaling $2,400. Mayra Loaiza, a resident of Piñas, is among those struggling to obtain the medication for her two-year-old daughter, Camila, who was expected to begin treatment six months ago but has yet to receive her first dose. Loaiza expresses concern about the impact of this delay on Camila’s growth and desires for her daughter to lead a normal life without discrimination due to her size.
Why It Matters
Laron syndrome is a rare genetic disorder that affects growth, and Increlex is one of the few treatment options available. The limited availability and high cost of the drug pose significant barriers for families seeking treatment, particularly in regions with fewer healthcare resources. The experiences of individuals like Mayra Loaiza highlight the challenges faced by families affected by this condition, emphasizing the need for improved access to essential medications. Historical context shows that advancements in medical treatments can significantly impact the quality of life for individuals with rare disorders.
Read the Full Story →
